about
The benefits and risks of testosterone replacement therapy: a reviewChange in Intra-Abdominal Fat Predicts the Risk of Hypertension in Japanese AmericansPsychosocial work environment and cardiovascular risk factors in an occupational cohort in FranceStress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic diseaseIncreased density of inhibitory noradrenergic parenchymal nerve fibers in hypertrophic islets of Langerhans of obese mice.Testosterone therapy in men: clinical and pharmacological perspectives.Hypertension and the metabolic syndrome: closely related central origin?Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.Man's two environments and disorders of civilization: aspects on prevention.Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic riskSex differences in type 2 diabetes: focus on disease course and outcomesAdipocyte metabolism and the metabolic syndrome.Heart and soul: stress and the metabolic syndrome.Stress-related development of obesity and cortisol in women.Measures of adiposity predict interleukin-6 responses to repeated psychosocial stress.Obesity and health risks.Cortisol is negatively associated with insulin sensitivity in overweight Latino youth.Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.Metabolic impact of body fat distribution.Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching.Gender-specific association between tobacco smoking and central obesity among 0.5 million Chinese people: the China Kadoorie Biobank Study.Testosterone supplementation: why and for whom?Obesity and cardiovascular risk: the new public health problem of worldwide proportions.Aetiology of obesity: a striving after wind?Obesogens, stem cells and the developmental programming of obesity.Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance.In search of a germ theory equivalent for chronic disease.The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects.Number of medications is associated with outcomes in the elderly patient with metabolic syndrome.Anatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone.Obesity in minority populations: an epidemiologic assessment.Anxiety and depression symptoms in patients with sleep-disordered breathingDiurnal salivary cortisol is associated with body mass index and waist circumference: the Multiethnic Study of AtherosclerosisRanking candidate genes in rat models of type 2 diabetes.Adipose tissue and metabolic syndrome: too much, too little or neither.Association between parity and obesity patterns in a middle-aged and older Chinese population: a cross-sectional analysis in the Tongji-Dongfeng cohort study.Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.Shortcuts to a functional adipose tissue: The role of small non-coding RNAs.Obesity, inflammation, and cardiovascular risk.
P2860
Q24658011-6B103E7E-4451-4224-B650-F66D2E910586Q27337148-D9E73C8F-11BD-4F35-A409-3F5A96FC8666Q28394217-09781F7E-8060-4309-B924-BD92022E3613Q33805504-7CB2DC1C-80D0-4A67-8F84-AEDC6ABF26B4Q33847356-A20DA57D-CCD6-4C85-9C39-57AD5AF66ECCQ33913912-AEF90FEE-A513-4268-9E76-75541F3A2754Q33944081-EA580C7C-0AB2-4998-A899-0C3ED1D9A1F8Q34014004-E1F6F668-9ABA-44E6-97A9-F9D466B74797Q34072340-D5B5EF0F-89DA-43B4-81B6-9DD2B616EE44Q34078148-599E0CD5-8040-49A0-B7CC-1AA8AEE8C475Q34229975-4D267ED8-7EAB-41DA-A93B-0F23C52C3DBCQ34285949-124C7A44-ED36-41D6-BE3F-DCEDF85CE60AQ34342507-3045A77D-E943-4CFF-A2C6-0E4CDB4BEE8BQ34605596-A56C6E3F-560A-4525-8FFF-FE9567D56DEAQ34613683-7CAAC286-083F-4048-B893-E24B8EDE3DC5Q34630698-FB309542-F618-4AC7-961C-6465CADDDD31Q34630733-362CDB68-9C7B-46DB-8C66-6434B97B7ED2Q34639781-52C83524-8656-4174-8630-37551C0CFF95Q34703328-40E5ACEC-0B10-4617-B645-06BA61F6E8F8Q35037257-13BA22D7-B889-4A23-AD97-9DBF25D55E18Q35087787-53BCB109-4781-4C29-9EEC-D822A64AD39CQ35515756-8E90B785-D743-4610-B99F-71747D769445Q35589227-6E76261E-058F-42FF-A053-F4EF1CEFE324Q35777356-373F742E-7118-4D58-96B7-3C69AEBE61EDQ35905498-703B074B-81B1-4FB3-802F-5A1719663007Q35980782-36ED6FE2-ABA0-4B59-A6DE-C43DC9A659DFQ36022706-33D977F6-3AE4-4DAC-87B2-F5B5B18D8D85Q36202788-5A66FCF0-CCFC-4CAB-9C88-EE8809C27FB3Q36297743-E9E1EAD1-F04F-4C98-9B72-E49EA5D4D41DQ36313635-D24D940C-6660-4CE3-876D-A38D5A4FEFB9Q36321357-D4EFD9D1-BBB6-4E49-8C63-DE56549C860EQ36341476-39425D88-7332-4D66-9B78-699B485AE2E4Q36345894-B7CA335E-E847-49ED-A895-10882D058F54Q36698772-2E1EEE67-B37E-440B-B9D4-5D60650BD098Q37259948-3607D951-E502-4E51-B2AD-895EE832347DQ37308618-ECA62976-09E7-4047-86E9-678853B3D04BQ37369977-B7E0777C-004F-4D97-915D-D44105B10259Q37622016-C7039FA8-F548-4E78-BD7C-FF75F8914F9BQ37645670-8DA21344-78A6-4A56-AE92-5852B78C4415Q37702091-79A46D0D-3D8B-40A9-A4C5-1AAD402409C8
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Visceral obesity: a "civilization syndrome".
@ast
Visceral obesity: a "civilization syndrome".
@en
type
label
Visceral obesity: a "civilization syndrome".
@ast
Visceral obesity: a "civilization syndrome".
@en
prefLabel
Visceral obesity: a "civilization syndrome".
@ast
Visceral obesity: a "civilization syndrome".
@en
P2860
P1433
P1476
Visceral obesity: a "civilization syndrome".
@en
P2860
P304
P356
10.1002/J.1550-8528.1993.TB00614.X
P577
1993-05-01T00:00:00Z